Extracorporeal Membrane Oxygenation (ECMO) Machine Market is expected to foresee significant growth. Asia-Pacific to lead the growth!

Extracorporeal Membrane Oxygenation (ECMO) Machine is a life support system that is to treat severe cardiac disorders such as cardiac shock or arrest, and they act as a heart and lungs outside the body. In ECMO a machine purifies the blood and makes a pathway for the blood circulation outside the body. It sends oxygen-filled blood into the human body and takeout the carbon dioxide-filled blood outside the body and the whole process is done in this ECMO therapy. Thus, due to the increase in the prevalence of CVD coupled with growing awareness of the benefits of ECMO such as maintaining the supply of oxygen to the body while resting the lungs. Thus, ECMO machines are also expected to witness considerable adoption in developing nations, growing at a CAGR of 5% during the forecast period.

In the U.S., about 18 million adults aged 20 and older have coronary artery disease (CAD). Furthermore, according to American Heart Association (AHA), coronary heart diseases cause 1 in every 7 deaths in the U.S., resulting in about 366,800 deaths each year. In addition, in 2020, there were 2.2 million new cases of lung cancer were reported.

For a detailed analysis of the market drivers browse through – https://univdatos.com/report/extracorporeal-membrane-oxygenation-machine-market/

Overall ECMO Machine industry is expected to witness strong and long-term demand, primarily due to A rise in chronic disease among end-users owing to the change in dietary habits, lifestyle, and other factors such as pollution, etc., contributes to the increasing demand for preventive healthcare technologies and solutions across the globe. In addition, the outbreak of the COVID-19 pandemic had a slight positive impact on the market growth due to increased cases of cardiac artery diseases (CAD) & lung diseases all over the globe.

Based on modality, the market is segmented into veno-arterial, veno-venous, and arterial-venous. Among these segments, arterial-venous (VA-ECMO) is projected to attain the largest market share in 2021 and is expected to increase with a healthy CAGR in the forecast period. The prevalence of Arterial-venous (VA-ECMO) promotes gas exchange, especially the removal of carbon dioxide, by pumping blood into the circulatory system using the patient’s arterial pressure.

For a detailed analysis of the Covid-19 Impact on the market browse through – https://univdatos.com/report/extracorporeal-membrane-oxygenation-machine-market/

Based on modality, the market is segmented into veno-arterial, veno-venous, and arterial-venous. Among these segments, arterial-venous (VA-ECMO) is projected to attain the largest market share in 2021 and is expected to increase with a healthy CAGR in the forecast period. The prevalence of Arterial-venous (VA-ECMO) promotes gas exchange, especially the removal of carbon dioxide, by pumping blood into the circulatory system using the patient’s arterial pressure

For a better understanding of the market, the report is analyzed based on different regions including North America (US, Canada, Rest of North America); Europe (Germany, UK, France, Italy, Spain Rest of Europe); Asia-Pacific (China, Japan, India, Australia, South Korea, Rest of Asia-Pacific); and Rest of World. North America accounts for the largest share of the market. Furthermore, the U.S. acquired the largest share in the North American market owing to the increasing prevalence of unhealthy lifestyles in youth coupled with the rising geriatric population in the country. According to the US Census Bureau analysis, the elderly population is expected to nearly double in the next 25 years. Furthermore, the increment in the global prevalence of multiple cardiovascular diseases like coronary artery diseases (CAD), and respiratory diseases are the major factors for the growth of this market. In 2020, according to the World Health Organization, there are 227,875 new lung cancer cases diagnosed. According to World Population Ageing, in 2019, the elderly population of North America was 59.9 million which is expected to reach 96.2 million by 2050

Request for Sample of the report browse through – https://univdatos.com/get-a-free-sample-form-php/?product_id=20196

Some of the major players operating in the market Fresenius Medical Care AG & Co. KGaA, Getinge Group, Medtronic plc, Terumo Cardiovascular Systems Corporation, Nipro Corporation, Xenios AG, Alung Technologies, Inc., Livanova plc, Eurosets S.R.L., Abiomed.

ECMO Machine Market Segmentation

Market Insight, by modality

• Veno-Arterial
• Veno-Venous
• Arterial-Venous

Market Insight, by Application

• Cardiac
• Respiratory
• Extracorporeal cardiopulmonary resuscitation (ECPR)

Market Insight, by Mode of Delivery

• Pumps
• Oxygenators
• Controllers
• Cannula
• Accessories

Market Insight, by End-User

• Hospitals & clinics
• Ambulatory Surgery centers
• others

Market Insight, by Region

• North America
  • United States
  • Canada
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
• Rest of World

Top Company Profiles

• Fresenius Medical Care AG & Co. KGaA
• Getinge Group• Medtronic plc• Terumo Cardiovascular Systems Corporation• Nipro Corporation• Xenios AG• Alung Technologies, Inc.• Livanova plc• Eurosets S.R.L.• Abiomed